US Stock MarketDetailed Quotes
ATRC AtriCure
- 36.180
- +0.390+1.09%
Trading Nov 27 14:48 ET
1.76BMarket Cap-43590P/E (TTM)
36.470High35.915Low107.67KVolume36.140Open35.790Pre Close3.89MTurnover0.23%Turnover RatioLossP/E (Static)48.75MShares39.04552wk High3.79P/B1.70BFloat Cap18.94052wk Low--Dividend TTM47.09MShs Float89.180Historical High--Div YieldTTM1.55%Amplitude1.000Historical Low36.112Avg Price1Lot Size
AtriCure Stock Forum
Sign in to post a comment
$Garmin (GRMN.US)$ $AtriCure (ATRC.US)$ $Vast Renewables (VSTE.US)$ $ASP Isotopes (ASPI.US)$ $Unisys (UIS.US)$ $Solidion Technology (STI.US)$ $NerdWallet (NRDS.US)$ $Xilio Therapeutics (XLO.US)$ $Cryo-Cell International (CCEL.US)$ $Omnicell (OMCL.US)$ $Reddit (RDDT.US)$ $Ensysce Biosciences (ENSC.US)$ $Tharimmune (THAR.US)$
5
1
$SeaStar Medical (ICU.US)$ $Direxion Daily GOOGL Bull 2X Shares (GGLL.US)$ $Torrid (CURV.US)$ $Snap Inc (SNAP.US)$ $60 Degrees Pharmaceuticals (SXTP.US)$ $GlycoMimetics (GLYC.US)$ $Mirion (MIR.US)$ $AtriCure (ATRC.US)$ $Reddit (RDDT.US)$ $Magic Empire Global (MEGL.US)$ $Sky Quarry (SKYQ.US)$ $Enovix (ENVX.US)$ $NerdWallet (NRDS.US)$ $Starbox Group (STBX.US)$
📊⚡️📊
📊⚡️📊
3
Insider transactions at AtriCure are not encouraging. However, insiders' share ownership suggests some alignment. Maggie Yuen's sale at a price above the current share price may not reflect insider confidence.
Investors forecast sustained strong revenue performance from AtriCure, reflected in a high P/S ratio. Shareholders currently show confidence in the company's future revenue, bolstering its shares. The high P/S ratio is deemed appropriate due to robust future revenues.
The lack of insider purchasing and ample selling in the past year could be red flags for potential investors in AtriCure. Despite high insider ownership, absence of buying is unsettling. Additionally, unspecified risks and concerns for AtriCure are noteworthy.
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Den the Dragon :
